How Metformin Can Impact Long COVID and Diabetes Management
THURSDAY, Sept. 19, 2024 (HealthDay News) -- One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID.
Long COVID can present with symptoms including chronic fatigue, brain fog, and chest pain and may last weeks or months after an initial COVID infection. It's thought that millions of Americans suffer from the illness.
As the researchers note, one study published last year found that overweight or obese COVID patients who took metformin soon after infection had a 41% reduction in their odds for Long COVID.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.